Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

NACompletedINTERVENTIONAL
Enrollment

2,600

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Post-ERCP Acute Pancreatitis
Interventions
DRUG

Pre-ERCP rectal Indomethacin

Rectal Indomethacin was administrated within 30min before ERCP in all patients.

DRUG

Post-operational Rectal Indomethacin

Rectal Indomethacin was administrated immediately after ERCP in high-risk patients, while average risk patients did not.

Trial Locations (6)

710032

Xijing Hospital of Digestive Diseases, Xi'an

710054

No. 451 Hospital, Xi'an

710061

The First Affiliated Hospital Of Xi'an Jiaotong University, Xi'an

730000

The First Hospital of Lanzhou University, Lanzhou

750004

General Hospital of NingXia Medical University, Yinchuan

830002

Urumqi General Hospital of Lanzhou Military Region, Ürümqi

All Listed Sponsors
lead

Air Force Military Medical University, China

OTHER

NCT02002650 - Rectal Indomethacin to Prevent Post-ERCP Pancreatitis | Biotech Hunter | Biotech Hunter